once daily s.c. on days 4–10 • Fever subsided by day 3
• CRP normalized in 5 patients by day 11
• Halted progression of CT lung lesions
• 100% survival • Small case series, potential for confounding factors
• Potential therapy to target inflammatory cascade
• Positive results in patients with hypertension and other CVD r